Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT is poised for growth due to its strong focus on healthcare real estate assets, particularly in the skilled nursing and seniors housing sectors. The company has a track record of successful acquisitions and a solid pipeline for future deals, leading to potential revenue and earnings growth in the coming years. Additionally, their commitment to sustainability and increasing focus on ESG metrics may attract socially responsible investors and potentially drive up the stock price.

Bears say

CareTrust REIT is a healthcare REIT that has been aggressive in deploying capital, completing $1.4 billion of deals year-to-date and having a $540 million investment pipeline. Despite well-positioned to deploy capital accretively, it is shifting its focus to companies that can benefit directly from the strong fundamental tailwinds via organic growth. Their investment activity comprises mostly SNF opportunities and strategic loans, which could drive future earnings growth.

CareTrust REIT (CTRE) has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 10 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.